APC/Cyanine7 anti-mouse Ly-6G Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Ly-6G transfected EL-4J cell line.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Red Laser (633 nm)

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C¹⁵. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A8¹⁵. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.4¹⁶.

Additional reported applications (for the relevant formats) include: immunohistochemistry⁹ of frozen sections¹⁰ and paraffin-embedded sections¹¹, depletion^{4, 12-14}, and spatial biology (IBEX)^20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Däbritz J, et al. 2016. Sci Rep. 6:20584. PubMed
2. Zaman R, et al. 2021. Immunity. :. PubMed
3. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
4. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
6. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
7. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
8. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
9. Ivan DC, et al. 2023. Acta Neuropathol Commun. 11:35. PubMed
10. Chung KJ, et al. 2023. Int J Mol Sci. 24:. PubMed
11. Houlder E, et al. 2023. Nat Commun. 14:1863. PubMed
12. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
13. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
14. Yashchenko A, et al. 2023. Front Immunol. 14:1082078. PubMed
15. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
16. Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed
17. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
18. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
19. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
20. McCauley KE, et al. 2022. Cell Rep Med. 3:100713. PubMed
21. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
22. Klapproth E, et al. 2022. Nat Commun. 13:7648. PubMed
23. Chen O, et al. 2023. J Clin Invest. 133: . PubMed
24. Li J, et al. 2023. Nat Commun. 14:159. PubMed
25. Xu R 2023. Cell Reports. 42(2):112054. PubMed
26. Tunali G, et al. 2023. J Clin Invest. :. PubMed
27. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
28. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
29. Kim EH, et al. 2020. Elife. 9:00. PubMed
30. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
31. Hastings AK, et al. 2019. iScience. 13:339. PubMed
32. Regev O, et al. 2022. Front Immunol. 13:849701. PubMed
33. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
34. Deng J, et al. 2021. JCI Insight. 6:146133. PubMed
35. Price P, et al. 2014. J Virol. 88:10840. PubMed
36. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
37. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
38. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
39. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
40. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
41. Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed
42. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
43. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
44. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
45. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
46. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
47. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
48. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
49. Yang C, et al. 2020. J Control Release. 326:324. PubMed
50. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
51. Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed
52. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
53. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
54. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
55. Kovács B, et al. 2020. Front Immunol. 2.508333333. PubMed
56. Anderson MC, et al. 2018. Cell Chem Biol. 25:483. PubMed
57. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
58. Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
59. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
60. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
61. Woods T, et al. 2016. J Virol. 90: 2783 - 2793. PubMed
62. Zhang J, et al. 2015. Sci Rep. 5: 15553. PubMed
63. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
64. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
65. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
66. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
67. Stutz MD, et al. 2021. Immunity. 54(8):1758-1771.e7. PubMed
68. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
69. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
70. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
71. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
72. Saha S, et al. 2016. Nat Commun. 7:13096. PubMed
73. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
74. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
75. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
76. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
77. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
78. Wilson R, et al. 2016. Nat Commun. 7:13597. PubMed
79. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
80. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
81. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
82. Wang SK, et al. 2021. JCI Insight. 6: . PubMed
83. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
84. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
85. Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed
86. Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed
87. Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed
88. Kalafati L, et al. 2020. Cell. 183:771. PubMed
89. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
90. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
91. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
92. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
93. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
94. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
95. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
96. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
97. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
98. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
99. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
100. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
101. Briukhovetska D, et al. 2020. Frontiers in Immunology. 1.428472222. PubMed
102. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
103. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
104. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
105. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
106. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
107. Ni Y, et al. 2021. Theranostics. 11:9431. PubMed
108. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
109. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
110. Zhang L, et al. 2020. Cell. 442:181. PubMed
111. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
112. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
113. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
114. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
115. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
116. Woods PS, et al. 2020. Am J Respir Cell Mol Biol. 62:243. PubMed
117. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
118. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
119. Dodd RD, et al. 2017. Cancer Res. 77:4486. PubMed
120. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
121. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
122. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
123. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
124. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
125. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
126. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
127. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
128. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
129. Davis FM, et al. 2021. J Exp Med. 218:. PubMed

RRID

AB_10645331 (BioLegend Cat. No. 127623)
AB_10645331 (BioLegend Cat. No. 127624)

Antigen Details

Structure

A 21-35 kD GPI-anchorded membrane protein

Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type

Granulocytes, Macrophages, Monocytes

Biology Area

Immunology, Innate Immunity

Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID

546644 View all products for this Gene ID

UniProt

View information about Ly-6G on UniProt.org

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Other Formats